Repreve and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Repreve (ropinirole).
Ropinirole Food
Moderate Food Interaction
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
References (4)
- Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
- Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
- (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
- (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc
Switch to consumer interaction data
Repreve drug interactions
There are 307 drug interactions with Repreve (ropinirole).
Repreve disease interactions
There are 6 disease interactions with Repreve (ropinirole) which include:
- neuroleptic malignant syndrome
- hypotension
- psychosis
- cardiovascular disease
- hepatic dysfunction
- renal dysfunction
More about Repreve (ropinirole)
- Check interactions
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Levodopa
Levodopa systemic is used for parkinson's disease, parkinsonism, periodic limb movement disorder ...
Amantadine
Easy-to-read patient leaflet for amantadine. Includes indications, proper use, special ...
Carbidopa/levodopa
Carbidopa/levodopa systemic is used for GTP-CH Deficiency, neuroleptic malignant syndrome ...
Rivastigmine
Rivastigmine systemic is used for alzheimer's disease, lewy body dementia, parkinson's disease
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.